Literature DB >> 7552588

Inflammatory mediators and bronchopulmonary dysplasia.

P Groneck1, C P Speer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7552588      PMCID： PMC2528371          DOI： 10.1136/fn.73.1.f1

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN： 1359-2998            Impact factor:   5.747


× No keyword cloud information.
  23 in total

Review 1.  Oxygen toxicity in the neonatal period.

Authors:  O D Saugstad
Journal:  Acta Paediatr Scand       Date:  1990-10

2.  Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes.

Authors:  J M Grigg; A Barber; M Silverman
Journal:  Am Rev Respir Dis       Date:  1992-04

3.  Increased airway leukotriene levels in infants with severe bronchopulmonary dysplasia.

Authors:  R Mirro; W Armstead; C Leffler
Journal:  Am J Dis Child       Date:  1990-02

4.  Risk factors for the degradation of lung elastic fibers in the ventilated neonate. Implications for impaired lung development in bronchopulmonary dysplasia.

Authors:  M C Bruce; M Schuyler; R J Martin; B C Starcher; J F Tomashefski; K E Wedig
Journal:  Am Rev Respir Dis       Date:  1992-07

5.  Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia.

Authors:  M C Yoder; R Chua; R Tepper
Journal:  Am Rev Respir Dis       Date:  1991-05

6.  Sequential changes in pulmonary mechanics in the very low birth weight (less than or equal to 1000 grams) infant.

Authors:  J S Greenspan; S Abbasi; V K Bhutani
Journal:  J Pediatr       Date:  1988-10       Impact factor: 4.406

7.  Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment.

Authors:  S H Murch; T T MacDonald; C B Wood; K L Costeloe
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

8.  Elastase alpha 1-proteinase inhibitor and lactoferrin concentrations in endotracheal aspirates of ventilated newborns.

Authors:  F K Tegtmeyer; S Maacks; W G Wood; W Wiebicke
Journal:  Pediatr Pulmonol       Date:  1992-06

9.  Alveolar macrophage status in bronchopulmonary dysplasia.

Authors:  A Clement; K Chadelat; A Sardet; A Grimfeld; G Tournier
Journal:  Pediatr Res       Date:  1988-05       Impact factor: 3.756

10.  Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections.

Authors:  H Walti; C Tordet; L Gerbaut; P Saugier; G Moriette; J P Relier
Journal:  Pediatr Res       Date:  1989-10       Impact factor: 3.756
View more
  21 in total

1.  Early use of high frequency ventilation in the premature neonate.

Authors:  Patrick Van Reempts; Christel Borstlap; Sabine Laroche; Jean-Claude Van der Auwera
Journal:  Eur J Pediatr       Date:  2003-02-04       Impact factor: 3.183

Review 2.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

3.  Population-based study of bronchopulmonary dysplasia in very low birth weight infants in Switzerland.

Authors:  Juliane Hentschel; Thomas M Berger; Alois Tschopp; Martina Müller; Mark Adams; Hans-Ulrich Bucher
Journal:  Eur J Pediatr       Date:  2005-02-15       Impact factor: 3.183

Review 4.  Effects of antenatal and postnatal corticosteroids on the preterm lung.

Authors:  J Vyas; S Kotecha
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

5.  Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants.

Authors:  B Jónsson; K Tullus; A Brauner; Y Lu; G Noack
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

6.  Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS.

Authors:  Marla R Wolfson; Jichuan Wu; Terrence L Hubert; Timothy J Gregory; Jan Mazela; Thomas H Shaffer
Journal:  Pediatr Res       Date:  2012-07-20       Impact factor: 3.756

7.  NICU bedside caregivers sustain process improvement and decrease incidence of bronchopulmonary dysplasia in infants < 30 weeks gestation.

Authors:  Sara J Mola; David J Annibale; Carol L Wagner; Thomas C Hulsey; Sarah N Taylor
Journal:  Respir Care       Date:  2014-11-25       Impact factor: 2.258

8.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

9.  Suppressive effects of breast milk on oxidative DNA damage in very low birthweight infants.

Authors:  H Shoji; T Shimizu; K Shinohara; S Oguchi; S Shiga; Y Yamashiro
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

10.  Glutathion-S-Transferase P1 polymorphisms association with broncopulmonary dysplasia in preterm infants.

Authors:  P Karagianni; D Rallis; L Fidani; M Porpodi; K Kalinderi; C Tsakalidis; N Nikolaidis
Journal:  Hippokratia       Date:  2013-10       Impact factor: 0.471
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.